Abstract
Stromal cells from DBA/2 mouse bone marrow have been shown to be susceptible to cytotoxicity induced by several redox-active metabolites of benzene, including hydroquinone (HQ). Treatment with HQ also alters the composition of stromal cell populations by preferentially killing stromal macrophages compared to stromal fibroblasts. This cytotoxicity can be prevented by 1,2-dithiole-3-thione (DTT) as a result of the induction of quinone reductase (QR), a quinone-processing enzyme, and glutathione. The inductive activities of DTT protected stromal cells against HQ-induced cytotoxicity and against HQ-induced impairment of stromal cell ability to support myelopoiesis. In vivo feeding of DTT to DBA/2 mice increased QR activity within the bone marrow compartment and protected bone marrow stromal cells isolated from the DTT-fed animals from ex vivo HQ challenge. Thus, the inducibility of cellular defense mechanisms and xenobiotic-processing enzymes by chemoprotective agents such as DTT may be a useful strategy for protecting against chemically induced bone marrow toxicities.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- De Long M. J., Prochaska H. J., Talalay P. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci U S A. 1986 Feb;83(3):787–791. doi: 10.1073/pnas.83.3.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaido K., Wierda D. In vitro effects of benzene metabolites on mouse bone marrow stromal cells. Toxicol Appl Pharmacol. 1984 Oct;76(1):45–55. doi: 10.1016/0041-008x(84)90027-9. [DOI] [PubMed] [Google Scholar]
- Kappus H., Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia. 1981 Dec 15;37(12):1233–1241. doi: 10.1007/BF01948335. [DOI] [PubMed] [Google Scholar]
- Kensler T. W., Egner P. A., Dolan P. M., Groopman J. D., Roebuck B. D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 1987 Aug 15;47(16):4271–4277. [PubMed] [Google Scholar]
- Kensler T. W., Egner P. A., Trush M. A., Bueding E., Groopman J. D. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis. 1985 May;6(5):759–763. doi: 10.1093/carcin/6.5.759. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Legraverend C., Harrison D. E., Ruscetti F. W., Nebert D. W. Bone marrow toxicity induced by oral benzo[a]pyrene: protection resides at the level of the intestine and liver. Toxicol Appl Pharmacol. 1983 Sep 30;70(3):390–401. doi: 10.1016/0041-008x(83)90157-6. [DOI] [PubMed] [Google Scholar]
- Løvhaug D., Pelus L. M., Nordlie E. M., Bøyum A., Moore M. A. Monocyte-conditioned medium and interleukin 1 induce granulocyte-macrophage colony-stimulating factor production in the adherent cell layer of murine bone marrow cultures. Exp Hematol. 1986 Dec;14(11):1037–1042. [PubMed] [Google Scholar]
- Nebert D. W. The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymes. Drug Metab Dispos. 1988 Jan-Feb;16(1):1–8. [PubMed] [Google Scholar]
- Oliver J. P., Goldstein A. L. Rapid method for preparing bone marrow cells from small laboratory animals. J Immunol Methods. 1978;19(2-3):289–292. doi: 10.1016/0022-1759(78)90188-6. [DOI] [PubMed] [Google Scholar]
- Prochaska H. J., Santamaria A. B. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem. 1988 Mar;169(2):328–336. doi: 10.1016/0003-2697(88)90292-8. [DOI] [PubMed] [Google Scholar]
- Prochaska H. J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 1988 Sep 1;48(17):4776–4782. [PubMed] [Google Scholar]
- Rennick D., Yang G., Gemmell L., Lee F. Control of hemopoiesis by a bone marrow stromal cell clone: lipopolysaccharide- and interleukin-1-inducible production of colony-stimulating factors. Blood. 1987 Feb;69(2):682–691. [PubMed] [Google Scholar]
- Renz J. F., Kalf G. F. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha. Blood. 1991 Aug 15;78(4):938–944. [PubMed] [Google Scholar]
- Ross D., Siegel D., Gibson N. W., Pacheco D., Thomas D. J., Reasor M., Wierda D. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radic Res Commun. 1990;8(4-6):373–381. doi: 10.3109/10715769009053371. [DOI] [PubMed] [Google Scholar]
- Smart R. C., Zannoni V. G. DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol. 1984 Jul;26(1):105–111. [PubMed] [Google Scholar]
- Talalay P., Benson A. M. Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv Enzyme Regul. 1982;20:287–300. doi: 10.1016/0065-2571(82)90021-8. [DOI] [PubMed] [Google Scholar]
- Thomas D. J., Reasor M. J., Wierda D. Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. Toxicol Appl Pharmacol. 1989 Mar 1;97(3):440–453. doi: 10.1016/0041-008x(89)90249-4. [DOI] [PubMed] [Google Scholar]
- Thomas D. J., Sadler A., Subrahmanyam V. V., Siegel D., Reasor M. J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol Pharmacol. 1990 Feb;37(2):255–262. [PubMed] [Google Scholar]
- Trentin J. J. Determination of bone marrow stem cell differentiation by stromal hemopoietic inductive microenvironments (HIM). Am J Pathol. 1971 Dec;65(3):621–628. [PMC free article] [PubMed] [Google Scholar]
- Twerdok L. E., Rembish S. J., Trush M. A. Induction of quinone reductase and glutathione in bone marrow cells by 1,2-dithiole-3-thione: effect on hydroquinone-induced cytotoxicity. Toxicol Appl Pharmacol. 1992 Feb;112(2):273–281. doi: 10.1016/0041-008x(92)90197-z. [DOI] [PubMed] [Google Scholar]
- Twerdok L. E., Trush M. A. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res Commun Chem Pathol Pharmacol. 1990 Mar;67(3):375–386. [PubMed] [Google Scholar]
- Zipori D., Bol S. The role of fibroblastoid cells and macrophages from mouse bone marrow in the in vitro growth promotion of haemopoietic tumour cells. Exp Hematol. 1979 Apr;7(4):206–218. [PubMed] [Google Scholar]
- Zucali J. R., Dinarello C. A., Oblon D. J., Gross M. A., Anderson L., Weiner R. S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986 Jun;77(6):1857–1863. doi: 10.1172/JCI112512. [DOI] [PMC free article] [PubMed] [Google Scholar]
